Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies ; volume:21 ; number:1 ; day:7 ; month:5 ; year:2024 ; pages:1-13 ; date:12.2024
Virology journal ; 21, Heft 1 (7.5.2024), 1-13, 12.2024
- Creator
-
Feng, Shuchen
Reid, Gail E.
Clark, Nina M.
Harrington, Amanda
Uprichard, Susan L.
Baker, Susan C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12985-024-02378-y
- URN
-
urn:nbn:de:101:1-2407180815272.277181247811
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Feng, Shuchen
- Reid, Gail E.
- Clark, Nina M.
- Harrington, Amanda
- Uprichard, Susan L.
- Baker, Susan C.
- SpringerLink (Online service)
Other Objects (12)
Convergent evolution of SARS-CoV-2 in human and animals
Lack of antiviral activity of darunavir against SARS-CoV-2
SARS-CoV-2 RNA polymerase as target for antiviral therapy
Immunoliposomes As a Promising Antiviral Agent against SARS-CoV-2
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
Body temperature-controlled antiviral response and SARS-CoV-2 replication
Antiviral molecules for the intervention of SARS-CoV-2 infections
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2
The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS‐CoV‐2
Convergent evolution of SARS-CoV-2 in human and animals
Lack of antiviral activity of darunavir against SARS-CoV-2
SARS-CoV-2 RNA polymerase as target for antiviral therapy
Immunoliposomes As a Promising Antiviral Agent against SARS-CoV-2
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
Body temperature-controlled antiviral response and SARS-CoV-2 replication
Antiviral molecules for the intervention of SARS-CoV-2 infections
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2
The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS‐CoV‐2
Convergent evolution of SARS-CoV-2 in human and animals
Lack of antiviral activity of darunavir against SARS-CoV-2
SARS-CoV-2 RNA polymerase as target for antiviral therapy
Immunoliposomes As a Promising Antiviral Agent against SARS-CoV-2
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
Body temperature-controlled antiviral response and SARS-CoV-2 replication
Antiviral molecules for the intervention of SARS-CoV-2 infections
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2
The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants